Longevity Report · Week of August 1, 2026
Sleep behavior, muscle strength, protein sources, GLP-1 expansion, and clock reliability under scrutiny
- Poor Sleep Behavior Tied to 172 Diseases: Rhythm and Fragmentation Overtake DurationGo to bed after 12:30 a.m. and your risk of liver cirrhosis runs 2.57 times higher than if you'd turned in between 11:00 and 11:30. Not "sleep less" — sleep later, and less regularly. That single hazard ratio, drawn from…
- Muscle Mass and Strength Outpredict BMI for Survival, With New Neural Clues to WeaknessArticle — "Muscle Mass and Strength Outpredict BMI for Survival, With New Neural Clues to Weakness": Article — "Muscle Mass and Strength Outpredict BMI for Survival, With New Neural Clues to Weakness": Everyone quotes th…
- Protein Quality Reconsidered: Amino Acid Composition May Beat Total Grams for AgingMice on the longevity diet ate as many calories as any other group and lost fat anyway—without losing lean mass. That single result, from Valter Longo's team at USC, is the crack in a definition of protein quality that h…
- GLP-1 Agonists in Heart Failure and Parkinson's: Signals Outrunning EvidenceHere is a number that should end the argument. In patients with reduced-ejection-fraction heart failure and type 2 diabetes, adding a GLP-1 receptor agonist to guideline-directed medical therapy dropped 18-month all-caus…
- Epigenetic Clocks Are Reproducible but Biologically Unstable: Short-Term Stress Skews Aging ReadoutsSplit one tube of blood across a dozen labs, hand each portion to the same principal-component epigenetic clock, and the answers will land within a fraction of a year of each other. That is the reassuring picture: a test…
Threads we are following
- Whether an intervention trial enforcing regular bedtime actually moves disease risk in a defined patient group
- Whether bundling resistance coaching into GLP-1 prescriptions actually improves function and survival outcomes
- Whether Longo and Fanti's proposed human clinical trial of the methionine-supplemented longevity diet gets funded and launched
- Whether phenotype-specific randomized HFrEF trials of GLP-1 RAs, once run, confirm harm, benefit, or neutrality on hospitalization.
- Will the Higgins-Chen lab's proposed controlled follow-up isolate a specific stressor from the passage of hours, and can next-generation clocks be engineered for short-term stability?
One issue a week. Free.
sift. reads hundreds of sources so you don't have to, and sends one issue you can actually finish. No daily noise. Unsubscribe anytime.